Bio Digital Artificial Intelligence
ENPICOM secures extended financing to continue driving breakthroughs in therapeutic discovery
ENPICOM, an innovative bioinformatics software engineering company, has successfully secured further financial backing from its current investors BOP Capit...
July 07, 2023 | News
Lunit's AI Solution Impacts Radiologists' Lung Cancer Diagnosis - Published in Radiology
Findings from a recent study demonstrate that medical AI solutions with only high diagnostic accuracy can significantly improve the reading performance of ...
July 04, 2023 | News
AI-Designed Drug Enters Phase II Trials, First Patients Dosed by Insilico Medicine
After completing the Phase 0 and Phase I human safety studies, INS018_055, Insilico's AI-discovered and AI-generated drug, has ent...
June 28, 2023 | News
Japan Approves CXR-AID for Reimbursement, Boosting Market Expansion for Lunit
Lunit (KRX:328130.KQ), a global provider of cancer diagnostics solutions, today announced that CXR-AID, FujiFilm's AI solution for chest X-ray analysis, po...
June 27, 2023 | News
South Korea's DeepCatch AI Software Receives US FDA Clearance for Whole-Body CT Quantification
The world's first FDA cleared solution that automatically analyzes bone, muscle, visceral fat, subcutaneous fat, internal organ, and central nerv...
June 27, 2023 | News
FUJIFILM Irvine Scientific Enhances Life Whisperer Platform for IVF Clinical Decision-Making
FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the Life Science and Medical markets, tod...
June 23, 2023 | News
Cognizant and Accuray Partner to Drive Operational Efficiency in Radiation Therapy Business
Cognizant (NASDAQ: CTSH) announced that it is partnering with Accuray Incorporated (NASDAQ: ARAY) to support the company's deplo...
June 22, 2023 | News
Beaconcure Raises $14 Million Series B to Expand AI-powered Clinical Technology Platform
NewVale Capital leads $14 Million Series B growth round Industry leading executive, Rick Riegel, joins as Chairman of the Board Newly formed Strategic ...
June 14, 2023 | News
Lunit's Groundbreaking AI Research Transforms Medical Pathology with Computer Vision, Presented at CVPR 2023
Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer diagnostic solutions, announced its participation in the Conference on Computer...
June 13, 2023 | News
HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Parkinson's Disease Collaboration
HanAll Biopharma and Daewoong Pharmaceutical have co-invested in Vincere Biosciences. These mission-aligned companies are collaborating to develop small...
June 13, 2023 | News
Nucleai & Mayo Clinic Partner to Revolutionize Digital Pathology in Drug Development & Clinical Practice
This collaboration combines Nucleai’s AI-powered spatial biology technology with Mayo’s longitudinally annotated, multi-modal data sets, world-...
June 05, 2023 | News
GC Biopharma Licensed to Build Plasma Fractionation Plant in Indonesia
GC Biopharma, a South Korean biopharmaceutical company, announced on Jun. 1st that it has successfully obtained final approval from the Indonesia...
June 02, 2023 | News
Lunit and the JNCCHE Partner in AI Pathology to Advance Precision Oncology
Lunit (KRX:328130.KQ), a global provider of AI-powered cancer diagnostic solutions, today announced collaboration with the National Cancer Center...
May 31, 2023 | News
United Imaging Unveils AI-Driven Product Portfolio at CMEF 2023
The booth was divided into three main areas: integrated diagnosis and treatment, precision diagnosis, and prospective research. United Imaging's most cutti...
May 18, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
